← Back to Screener
Structure Therapeutics Inc. American Depositary Shares (GPCR)
Price$37.58
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-2.98%
Price vs S&P 500 (4W)-3.88%
VGM Score52.87
Market Capitalization$2.78B
All Metrics
Book Value / Share (Quarterly)$6.79
P/TBV (Annual)28.17x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.75
Price vs S&P 500 (YTD)-54.12%
EPS (TTM)$-0.91
10-Day Avg Trading Volume0.57M
EPS Excl Extra (TTM)$-0.91
EPS (Annual)$-0.80
ROI (Annual)-9.31%
Cash / Share (Quarterly)$6.84
ROA (Last FY)-8.91%
EBITD / Share (TTM)$-1.10
ROE (5Y Avg)-28.20%
Cash Flow / Share (Annual)$-1.06
P/B Ratio1.92x
P/B Ratio (Quarterly)2.36x
Net Income / Employee (Annual)$-641,800
Net Interest Coverage (TTM)-308.98x
ROA (TTM)-14.37%
EPS Incl Extra (Annual)$-0.80
Current Ratio (Annual)24.81x
Quick Ratio (Quarterly)25.59x
3-Month Avg Trading Volume0.89M
52-Week Price Return75.03%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$5.03
52-Week High$94.90
EPS Excl Extra (Annual)$-0.80
CapEx CAGR (5Y)185.66%
26-Week Price Return4.94%
Quick Ratio (Annual)24.43x
13-Week Price Return-37.05%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)26.16x
Enterprise Value$2.46B
Revenue / Employee (Annual)$0
Cash / Share (Annual)$6.81
3-Month Return Std Dev55.69%
Net Income / Employee (TTM)$-774,300
ROE (Last FY)-9.31%
EPS Basic Excl Extra (Annual)$-0.80
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.91
ROI (TTM)-15.12%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$2.32
Price vs S&P 500 (52W)50.67%
Year-to-Date Return-45.97%
5-Day Price Return-2.52%
EPS Normalized (Annual)$-0.80
ROA (5Y Avg)-25.55%
Month-to-Date Return-4.47%
Cash Flow / Share (TTM)$-2.24
EBITD / Share (Annual)$-0.99
ROI (5Y Avg)-28.20%
EPS Basic Excl Extra (TTM)$-0.91
P/TBV (Quarterly)12.38x
P/B Ratio (Annual)2.71x
Book Value / Share (Annual)$7.14
Price vs S&P 500 (13W)-45.31%
Beta-1.45x
Revenue / Share (TTM)$0.00
ROE (TTM)-15.12%
52-Week Low$15.80
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.35est. -0.35
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.32
4.26
4.25
4.25
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
GPCRStructure Therapeutics Inc. American Depositary Shares | — | — | C | $37.58 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Structure Therapeutics is a clinical-stage biopharmaceutical company developing oral small-molecule therapeutics targeting G-protein coupled receptors (GPCRs) for chronic diseases with unmet medical needs. The company's differentiated platform integrates structure-based drug discovery with computational chemistry expertise to advance its pipeline of potential medicines.